I agree with you on this
if…. The material growth policy from CBI only applies during remediation period then come March 2022 the company will have $160m+ at hand and we’ll be on a run rate circa $270-$300m turnover
were a much better business yoy with vaccines, 18 months of new programs under the hood (circa 200) + hopefully an uninterrupted Xmas trading season to boost full year profitability margins
time will tell I guess
ps good to see some old friends back in the thread!
I agree with you on thisif…. The material growth policy from CBI...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EML (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.5¢ |
Change
0.045(7.50%) |
Mkt cap ! $243.2M | |||
| Open | High | Low | Value | Volume |
| 60.5¢ | 65.5¢ | 60.5¢ | $1.108M | 1.739M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12534 | 64.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.0¢ | 26324 | 3 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| EML (ASX) Chart |